MedTrace Logo

Randomized Trial of Follow-up Strategies in Breast Cancer

NCT00156039 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 968

Last updated 2009-07-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether family physician 'routine follow-up care' of women with breast cancer in remission is an acceptable alternative to the existing system of specialist follow-up. Primary outcome measure are event rates of oncological catastrophes and quality of life.

Conditions

Interventions

BEHAVIORAL

Follow-up Strategy for Breast Cancer

Sponsors & Collaborators

  • Canadian Breast Cancer Initiative

    collaborator UNKNOWN

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Eva Grunfeld, MD · Cancer Care Nova Scotia

  • Mark Levine, MD · Ontario Clinical Oncology Group (OCOG)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-01-31
Completion
2003-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156039 on ClinicalTrials.gov